Optimer Is Up For Sale And Could Attract Hospital-Focused Suitors
This article was originally published in The Pink Sheet Daily
Executive Summary
The antibiotic company announced it is reviewing strategic options and that CEO Pedro Lichtinger has been replaced by Chairman Henry McKinnell. Hospital-based companies looking to beef up their portfolios with a commercial asset could drive a competitive process.